Back to Archived Journals » Biosimilars » Volume 5
Biosimilars ceased publishing in October 2016. All new submissions can be made to Biologics: Targets and Therapy. All articles that have been published in Biosimilars will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Biosimilars
ISSN: 2230-245X
- View all (31)
- Volume 6, 2016 (6)
- Volume 5, 2015 (9)
- Volume 4, 2014 (4)
- Volume 3, 2013 (6)
- Volume 2, 2012 (4)
- Volume 1, 2011 (2)
Archive: Volume 5, 2015
Pharmacokinetic and pharmacodynamic properties of a new biosimilar filgrastim TPI G-CSF in comparison to the marketed reference filgrastim Neupogen®: a double-blind, single-dose, two-period crossover trial
Niazi SK
Biosimilars 2015, 5:93-101
Published Date: 3 November 2015
Label-free interaction analysis as a tool to demonstrate biosimilarity of therapeutic monoclonal antibodies
Sinha-Datta U, Khan S, Wadgaonkar D
Biosimilars 2015, 5:83-91
Published Date: 16 September 2015
Low immunogenicity but reduced bioavailability of an interferon beta-1a biosimilar compared with its biological parent: results of MATRIX, a cross-sectional, multicenter phase 4 study
Cuevas C, Deisenhammer F, You X, Scolnik M, Buffels R, Sperling B, Flores-Ramírez F, Macías-Islas M, Sauri-Suárez S
Biosimilars 2015, 5:75-81
Published Date: 15 September 2015
Clinical efficacy and safety of biosimilar epoetin: focus on epoetin zeta
Mikhail A, Brown C
Biosimilars 2015, 5:65-73
Published Date: 9 September 2015
Clinical trials in the development of biosimilars: future considerations
Huneycutt BJ, Gillespie E, Woollett GR
Biosimilars 2015, 5:49-63
Published Date: 9 July 2015
Establishing a new marketplace for biologic therapy with biosimilar agents: importance of extrapolation of data
Bressler B, Dingermann T
Biosimilars 2015, 5:41-48
Published Date: 1 June 2015
Challenging issues in assessing analytical similarity in biosimilar studies
Chow SC
Biosimilars 2015, 5:33-39
Published Date: 22 May 2015
Global regulatory landscape of biosimilars: emerging and established market perspectives
Krishnan A, Mody R, Malhotra H
Biosimilars 2015, 5:19-32
Published Date: 17 February 2015
Physicochemical and functional characterization of a biosimilar adalimumab ZRC-3197
Bandyopadhyay S, Mahajan M, Mehta T, Singh AK, Parikh A, Gupta AK, Kalita P, Patel M, Mendiratta SK
Biosimilars 2015, 5:1-18
Published Date: 31 December 2014